Monitoring serial changes in circulating human breast cancer cells in murine xenograft models

TY - JOUR

T1 - Monitoring serial changes in circulating human breast cancer cells in murine xenograft models

AU - Eliane, Jean-Pierre

AU - Repollet, Madeline

AU - Luker, Kathryn E.

AU - Brown, Martha

AU - Rae, James M.

AU - Dontu, Gabriela

AU - Schott, Anne F.

AU - Wicha, Max

AU - Doyle, Gerald V.

AU - Hayes, Daniel F.

AU - Luker, Gary D.

PY - 2008/7/15

Y1 - 2008/7/15

N2 - Circulating tumor cells (CTC) are emerging as a powerful prognostic and predictive biomarker in several types of cancer, including breast, colon, and prostate. Studies of CTC in metastasis and further development of CTC as a biomarker in cancer have been limited by the inability to repetitively monitor CTC in mouse models of cancer. We have validated a method to enumerate CTC in blood samples obtained from living mice using a modified version of an in vitro diagnostic system for quantifying CTC in patients. Different routes of blood collection were tested to identify a method to reproducibly recover CTC from tumor-bearing mice without interference from contaminating normal murine epithelial cells. CTC are present in blood samples from mice bearing orthotopic xenografts of several different breast cancer cell lines and primary breast cancer cells from patient biopsies. We also show that this technology can be used for serial monitoring of CTC in mouse xenograft models of human breast cancer. These results establish a new method for studying CTC in mouse models of epithelial cancer, providing the foundation for studies of molecular regulation of CTC in cancer and CTC as biomarker for therapeutic efficacy.

AB - Circulating tumor cells (CTC) are emerging as a powerful prognostic and predictive biomarker in several types of cancer, including breast, colon, and prostate. Studies of CTC in metastasis and further development of CTC as a biomarker in cancer have been limited by the inability to repetitively monitor CTC in mouse models of cancer. We have validated a method to enumerate CTC in blood samples obtained from living mice using a modified version of an in vitro diagnostic system for quantifying CTC in patients. Different routes of blood collection were tested to identify a method to reproducibly recover CTC from tumor-bearing mice without interference from contaminating normal murine epithelial cells. CTC are present in blood samples from mice bearing orthotopic xenografts of several different breast cancer cell lines and primary breast cancer cells from patient biopsies. We also show that this technology can be used for serial monitoring of CTC in mouse xenograft models of human breast cancer. These results establish a new method for studying CTC in mouse models of epithelial cancer, providing the foundation for studies of molecular regulation of CTC in cancer and CTC as biomarker for therapeutic efficacy.

U2 - 10.1158/0008-5472.CAN-08-0630

DO - 10.1158/0008-5472.CAN-08-0630

M3 - Article

VL - 68

SP - 5529

EP - 5532

JO - Cancer Research

JF - Cancer Research

IS - 14

ER -